New break-through in eye disease treatment from the University of Waterloo

Blog vol 4.12. New break-through in eye disease treatment from the University of Waterloo


In 2018 Donna Strickland at the University of Waterloo won the Nobel Prize in Physics for her work with lasers.


University of Waterloo researchers are breaking ground again, this time in pharmacy, with the development of a new class of drugs for treatment in eye disease.  These drugs use a new protein that works with the Wnt-signaling network to help repair damaged blood vessels in the eye.


Off I go to Google and PubMed to research this topic. Not so easy. It is very involved molecular medicine. 


“Wnt proteins act as intercellular signals which regulate the proliferation of cells.” This is the definition provided by the Wnt network homepage from Stanford University.


I have read a good number of suspense novels, and I can tell you that one way to solve mysteries is to follow the money. In this case, we need to follow the molecules. Scientists have known about the Wnt signalling network for some time. This system works with stem cells and is involved in the embryonic development of organisms, specifically, how the tissues are developed. Abnormal signals or proteins produced by the signalling network can result in cancers or other malformations.


So, we need to find a way to create proteins that use the Wnt network to signal beneficial changes. Dr. Sachdev Sidhu, working in collaboration with Waterloo’s School of Pharmacy, has developed such as protein. This protein enters a cell through fizzled (yes, fizzled) receptors and by a series of changes results in a new substance, ß-catenin, which enters the nucleus and eventually works with Wnt genes, another part of the network (read more here). These genes are activated to help build up blood vessel integrity in the eye which is super-important in wet macular degeneration and diabetic retinopathy. 


In Wet Macular Degeneration the body produces too much VGEF, Vascular Endothelial Growth Factor, which encourages new vessel growth in the eye. This results in a proliferation of vessels which unfortunately are poor in quality. The best treatment currently is AntiVGEF injections into the eye to control VGEF production and prevent vision loss.


Ideally, we could stop the process further upstream and prevent the over-production of VGEF in the first place. This Wnt-signaling protein is in clinical trials and looks like it just might be able to do that.     


 

‘til next week,



 

the good doctor


The good doctor take a deeper look at how gut health is connected to eye tissues.
By Dr. Mark Germain April 29, 2026
Blog vol 6.40. The Gut and the Eyes. One of my biggest jobs is to keep abreast of new research and advances in eye health. Most recently, we have seen new stem cell research, gene therapies, as well as new drugs for dry and wet macular degeneration. In January of this year, there was an article in the journal, Cell Death and Disease, that looked at cell apoptosis, specifically with the photoreceptors of the eye. (Read the article here ). Apoptosis is the genetic programming of deliberate and constructive cell death, allowing for the maintenance of healthy structures and systems in the body. Some estimates have the body replacing 50 to 70 billion cells daily by this process. Necrosis, on the other hand, is unplanned cell death caused by injury, toxins, or other negative outside factors; this causes inflammation and disrupts the body’s balance of things. There are stressors that speed up cell turnover. The study looked at photoreceptors in the retina and were able to demonstrate cellular recovery, even in late stages of apoptosis, recovery not breakdown. When certain stressors were reduced, by working with the mitochondria, there was recovery of the photoreceptor cells. How? Mitophagy, the mitochondria’s own process of programmed breaking down and then repurposing the recycled components for new ones. This mitochondrial repair helps to reverse the sequence of apoptosis for the photoreceptors. Mitochondria, how cool. How is this helpful for our eyes? Conditions like retinitis pigmentosa or macular degeneration directly involve the photoreceptors and may be slowed or reversed by helping the mitochondria. So, let’s take care of those mitochondria. There is some evidence for nutritional support for the mitochondrial system. The nutrient, Urolithin A (UA), which is a compound made in our gut from fiber found in pomegranates, berries, and nuts is the only clinically proven substance known to trigger mitophagy, made in the gut no less. Vitamin B3 is critical for mitochondria function, however vitamin B3 based supplements are still to be clinically tested for their support of cell recovery. Nutrients Coenzyme Q10 and L-carnitine are known to help the mitochondria generate energy, and interestingly, infrared light therapy has also been shown to benefit mitochondrial function. Again, food for thought. The gut and its function needs a lot of research. How do probiotics and nutrient precursors affect eye tissues? It is so interesting that the gut can be a factor in eye health. Maybe adding Urolithin A as a supplement is wise, along with the antioxidants in Lutein and Zeaxanthin we use to combat photoreceptor degeneration. Will keep you posted on any new developments.  The good doctor
By Dr. Mark Germain April 16, 2026
The good doctor focuses in on visual processing. Why do we miss things that are right in front of our eyes?
By Dr. Mark Germain April 10, 2026
The good doctor discusses the Artemis II mission, space travels affects on the eyes, and "the dark side of the moon"
By Dr. Mark Germain April 3, 2026
The good doctor discusses exciting new and emerging options to treat nystagmus.
By Dr. Mark Germain March 27, 2026
The good doctor reflects on The Country of the Blind, a book by Andrew Leland which gives insight into the experience of vision loss.
By Dr. Mark Germain March 19, 2026
This week's blog focuses on the newest version of the Neurolens - a lens with technology that can provide relief for headaches, neck pain, and eye strain caused by trigeminal dysphoria.
More Posts